Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI)

CUSIP: 320703309

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
33,630,240
Total 13F shares
156,566
Share change
+156,566
Total reported value
$31,312
Price per share
$0.20
Number of holders
2
Value change
+$31,312
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 320703309?
CUSIP 320703309 identifies CLDI - Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) as of Q2 2024

As of 30 Jun 2024, Calidi Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (CLDI) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 156,566 shares. The largest 2 holders included Driehaus Capital Management LLC and MARSHALL WACE, LLP. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.